Array BioPharma Inc. (ARRY)

19.00
NASDAQ : Health Technology
Prev Close 19.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 7.15 / 19.02
Avg Volume 2.44M
Exchange NASDAQ
Shares Outstanding 210.64M
Market Cap 3.69B
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Array BioPharma Announces Additional Median Overall Survival Results Of Encorafenib And Binimetinib In Patients With BRAF-mutant Advanced Melanoma

Array BioPharma Announces Additional Median Overall Survival Results Of Encorafenib And Binimetinib In Patients With BRAF-mutant Advanced Melanoma

-- Combination of encorafenib and binimetinib achieved 33.6 month median overall survival --

Interesting ARRY Put And Call Options For December 21st

Investors in Array BioPharma Inc. saw new options begin trading this week, for the December 21st expiration.

Array BioPharma Announces Publication Of Detailed Phase 3 COLUMBUS Trial Data Of Encorafenib And Binimetinib In Melanoma Patients In The Lancet Oncology

Array BioPharma Announces Publication Of Detailed Phase 3 COLUMBUS Trial Data Of Encorafenib And Binimetinib In Melanoma Patients In The Lancet Oncology

- Trial Demonstrated a Median Progression-Free Survival of 14.9 Months Using Encorafenib and Binimetinib Combination -

February Trade Ideas Rundown: How'd We Do?

February Trade Ideas Rundown: How'd We Do?

A fresh look at all 17 ideas: the winners, the losers and the still to be determined.

An Aggressive Trade in Array Biopharma

An Aggressive Trade in Array Biopharma

Despite biotech losing a bit of its former headline grabbing attention, there are still plenty of great setups to be found.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Array Biopharma Inc. Of Class Action Lawsuit And Upcoming Deadline - ARRY

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Array Biopharma Inc. Of Class Action Lawsuit And Upcoming Deadline - ARRY

Pomerantz LLP announces that a class action lawsuit has been filed against Array Biopharma Inc.

Short Interest Drops 23.4% For ARRY

Short Interest Drops 23.4% For ARRY

The most recent short interest data has been released for the 12/15/2017 settlement date, which shows a 4,831,803 share decrease in total short interest for Array BioPharma Inc. , to 15,831,594, a decrease of 23.38% since 11/30/2017.

The Klein Law Firm Reminds Shareholders Of A Class Action On Behalf Of Array Biopharma Inc. Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm Reminds Shareholders Of A Class Action On Behalf Of Array Biopharma Inc. Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm notifies shareholders that a class action complaint has been filed on behalf of shareholders of Array Biopharma Inc.

ARRY EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Array Biopharma Inc. And A Lead Plaintiff Deadline Of January 22, 2018

ARRY EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Array Biopharma Inc. And A Lead Plaintiff Deadline Of January 22, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of investors who purchased Array Biopharma Inc.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Array BioPharma Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Array BioPharma Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of...

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed A Complaint On Behalf Of Array Biopharma Inc. Shareholders And Lead Plaintiff Deadline Of January 22, 2018

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed A Complaint On Behalf Of Array Biopharma Inc. Shareholders And Lead Plaintiff Deadline Of January 22, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Array Biopharma Inc.

The Klein Law Firm Notifies Shareholders Of A Class Action Commenced On Behalf Of Array Biopharma Inc. Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm Notifies Shareholders Of A Class Action Commenced On Behalf Of Array Biopharma Inc. Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm notifies shareholders that a class action complaint has been filed on behalf of shareholders of Array Biopharma Inc.

ARRY LOSS NOTICE: Rosen Law Firm Reminds Array Biopharma Inc. Investors Of Important Deadline In Class Action

ARRY LOSS NOTICE: Rosen Law Firm Reminds Array Biopharma Inc. Investors Of Important Deadline In Class Action

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Array Biopharma Inc.

This Isn't a Rally: Cramer's 'Mad Money' Recap (Monday 12/4/17)

This Isn't a Rally: Cramer's 'Mad Money' Recap (Monday 12/4/17)

Investors continued to rotate into domestic stocks seen benefiting from tax cuts, but without higher estimates, the gains could falter.

ARRY INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Array Biopharma Inc. And A Lead Plaintiff Deadline Of January 22, 2018

ARRY INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Array Biopharma Inc. And A Lead Plaintiff Deadline Of January 22, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Colorado on behalf of investors who purchased Array Biopharma Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed A Complaint On Behalf Of Array Biopharma Inc. Shareholders And Lead Plaintiff Deadline Of January 22, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed A Complaint On Behalf Of Array Biopharma Inc. Shareholders And Lead Plaintiff Deadline Of January 22, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Array Biopharma Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Array BioPharma Inc. - ARRY

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Array BioPharma Inc. - ARRY

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Array BioPharma Inc.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Array BioPharma Inc.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Array BioPharma Inc.

The Klein Law Firm announces the commencement of an investigation of Array BioPharma Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Array BioPharma Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Array BioPharma Inc.

The Klein Law Firm announces the commencement of an investigation of Array BioPharma Inc.

ARRY INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Array BioPharma Inc.

ARRY INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Array BioPharma Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Array BioPharma Inc.

ARRY SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Array BioPharma Inc.

ARRY SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Array BioPharma Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Array BioPharma Inc.

STMicroelectronics, Intercept Pharmaceuticals: 'Mad Money' Lightning Round

STMicroelectronics, Intercept Pharmaceuticals: 'Mad Money' Lightning Round

Jim Cramer is bullish on STMicroelectronics, Intercept Pharmaceuticals, Altria, and Array BioPharma.

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

Watch Out For the Dominoes That Fall: Cramer's 'Mad Money' Recap (Wed 9/20/17)

Jim Cramer says when this market gets some bad news after its remarkable run, investors have to break out the dominoes to explain the decline.

TheStreet Quant Rating: D (Sell)